Edition:
United Kingdom

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

2.39USD
9:00pm BST
Change (% chg)

$0.12 (+5.29%)
Prev Close
$2.27
Open
$2.28
Day's High
$2.49
Day's Low
$2.26
Volume
6,729
Avg. Vol
37,401
52-wk High
$5.96
52-wk Low
$1.18

Latest Key Developments (Source: Significant Developments)

Biostar Pharmaceuticals Files For Non-Timely 10-Q
Wednesday, 16 May 2018 

May 16 (Reuters) - Biostar Pharmaceuticals Inc ::BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC - SEC FILING.  Full Article

Biostar Pharma qtrly ‍loss per share $0.05
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biostar Pharmaceuticals Inc ::Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017.Biostar Pharmaceuticals Inc - qtrly ‍loss per share $0.05.  Full Article

Biostar Pharmaceuticals qtrly loss per share $‍0.50​
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017.Biostar Pharmaceuticals Inc - ‍during fiscal Q2 of 2017 company recognized no net sales​.Biostar Pharmaceuticals Inc qtrly loss per share $‍0.50​.  Full Article

Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd
Thursday, 22 Sep 2016 

Biostar Pharmaceuticals Inc : Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd . To buy 100% of equity interest in Xianyang Yongsheng in exchange for cash payment, issuance of shares of Biostar's restricted common stock .Companies seek to complete this transaction in second half of 2016.  Full Article

Biostar Pharmaceuticals reports qtrly loss per share $3.12
Monday, 22 Aug 2016 

Biostar Pharmaceuticals Inc : Announces its quarterly results for three months ended June 30, 2016 . Fiscal Q2 net sales of $0.6 million, a decrease of approximately $13.6 million .Qtrly loss per share $3.12.  Full Article

Biostar Pharmaceuticals files for non-timely 10-Q with U.S. SEC
Tuesday, 16 Aug 2016 

Biostar Pharmaceuticals Inc : Files for non-timely 10-Q with U.S. SEC - SEC filing .Says expects that quarterly report that is subject hereof will be filed within the time frame allowed by the extension.  Full Article

BRIEF-Biostar Pharmaceuticals Files For Non-Timely 10-Q

* BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC - SEC FILING Source http://bit.ly/2wLwd7M Further company coverage: